Cambridge Healthtech Institute Inaugural Target Discovery for T Cell Therapy

Target discovery remains one of the biggest challenges facing the immunotherapy field. With treatments becoming ready for prime-time, researchers will need to increase their discovery efforts to meet patient need and continue advancing the field.
Cambridge Healthtech Institute's Inaugural Target Discovery for T Cell Therapy will bring together leading academic and industry researchers to discuss how to find and validate suitable targets and antigens for T cell therapies.
Experts will share strategies for toxicity prediction and increasing specificity as well as best practices for start-to-finish discovery and manufacture. Clinical data will be showcased as well as in-depth examinations of where the field is headed.